„reprogramming“
Suchergebnisse
2.540 Treffer
-
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation
-
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy
-
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance
-
Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
-
KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
-
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
-
GMRSP encoded by lncRNA H19 regulates metabolic reprogramming and alleviates aortic dissection
-
Neuroreceptor Inhibition by Clozapine Triggers Mitohormesis and Metabolic Reprogramming in Human Blood Cells
-
Inflammatory memory-activated biomimetic nanovesicles regulate neutrophil plasticity and metabolic reprogramming for rapid diabetic wound healing via targeting miR-193a-5p/TLR4/JNK/P38 MAPK pathways
-
Oncofetal reprogramming induces phenotypic heterogeneity in colorectal cancer
-
Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer
-
High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming
-
LMNA R482L mutation causes impairments in C2C12 myoblasts subpopulations, alterations in metabolic reprogramming during differentiation, and oxidative stress
-
Placental and Fetal Metabolic Reprogramming in Pregnancies with Intrauterine Growth Restriction
-
CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK/T-cell lymphoma nasal type
-
STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8+ T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages
-
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors
-
Isoacteoside alleviates hepatocellular carcinoma progression by inhibiting PDHB-mediated reprogramming of glucose metabolism
-
D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming
-
Metabolic reprogramming of fibroblast-like synoviocytes with a supramolecular nano-drug for osteoarthritis therapy